Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thompson, W G
Right arrow Articles by Müller-Lissner, S A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thompson, W G
Right arrow Articles by Müller-Lissner, S A
Gut 1999;45(Suppl 2):II43-II47 ( September )

Functional bowel disorders and functional abdominal pain

W G Thompsona, G F Longstrethb, D A Drossmanc, K W Heatond, E J Irvinee, S A Müller-Lissnerf

a Chair, Committee on Functional Bowel Disorders and Functional Abdominal Pain, Multinational Working Teams to Develop Diagnostic Criteria for Functional Gastrointestinal Disorders (Rome II), Emeritus Professor of Medicine, University of Ottawa, Canada, b Co-Chair, Committee on Functional Bowel Disorders and Functional Abdominal Pain, Multinational Working Teams to Develop Diagnostic Criteria for Functional Gastrointestinal Disorders (Rome II), Kaiser Permanente, San Diego, CA, USA, c Division of Digestive Diseases, University of North Carolina, Chapel Hill, NC, USA, d Department of Medicine, University of Bristol, Bristol, UK, e Department of Medicine, McMaster University, Ontario, Canada, f Department of Medicine, Park-Klinik, Weissensee, Berlin, Germany

Correspondence to: W Grant Thompson, MD, 7 Nesbitt Street, Nepean, Ontario K2H 8C4, Canada.

The Rome diagnostic criteria for the functional bowel disorders and functional abdominal pain are used widely in research and practice. A committee consensus approach, including criticism from multinational expert reviewers, was used to revise the diagnostic criteria and update diagnosis and treatment recommendations, based on research results. The terminology was clarified and the diagnostic criteria and management recommendations were revised. A functional bowel disorder (FBD) is diagnosed by characteristic symptoms for at least 12 weeks during the preceding 12 months in the absence of a structural or biochemical explanation. The irritable bowel syndrome, functional abdominal bloating, functional constipation, and functional diarrhea are distinguished by symptom-based diagnostic criteria. Unspecified FBD lacks criteria for the other FBDs. Diagnostic testing is individualized, depending on patient age, primary symptom characteristics, and other clinical and laboratory features. Functional abdominal pain (FAP) is defined as either the FAP syndrome, which requires at least six months of pain with poor relation to gut function and loss of daily activities, or unspecified FAP, which lacks criteria for the FAP syndrome. An organic cause for the pain must be excluded, but aspects of the patient's pain behavior are of primary importance. Treatment of the FBDs relies upon confident diagnosis, explanation, and reassurance. Diet alteration, drug treatment, and psychotherapy may be beneficial, depending on the symptoms and psychological features.


Keywords: functional bowel disorder; functional constipation; functional diarrhea; irritable bowel syndrome; functional abdominal pain; functional abdominal bloating; Rome II


© 1999 by Gut



This article has been cited by other articles:


Home page
Palliat MedHome page
P. Larkin, N. Sykes, C Centeno, J. Ellershaw, F Elsner, B Eugene, J. Gootjes, M Nabal, A Noguera, C Ripamonti, et al.
The management of constipation in palliative care: clinical practice recommendations
Palliative Medicine, October 1, 2008; 22(7): 796 - 807.
[Abstract] [PDF]


Home page
Hum Mol GenetHome page
J. Kapeller, L. A. Houghton, H. Monnikes, J. Walstab, D. Moller, H. Bonisch, B. Burwinkel, F. Autschbach, B. Funke, F. Lasitschka, et al.
First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome
Hum. Mol. Genet., October 1, 2008; 17(19): 2967 - 2977.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
X Jiang, G R Locke III, R S Choung, A R Zinsmeister, C D Schleck, and N J Talley
Prevalence and risk factors for abdominal bloating and visible distention: a population-based study
Gut, June 1, 2008; 57(6): 756 - 763.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
T. J Kaptchuk, J. M Kelley, L. A Conboy, R. B Davis, C. E Kerr, E. E Jacobson, I. Kirsch, R. N Schyner, B. H. Nam, L. T Nguyen, et al.
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
BMJ, May 3, 2008; 336(7651): 999 - 1003.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
S. H. Yale, A. K. Musana, A. Kieke, J. Hayes, I. Glurich, and P.-H. Chyou
Applying Case Definition Criteria to Irritable Bowel Syndrome
Clin. Med. Res., May 1, 2008; 6(1): 9 - 16.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
K Gecse, R Roka, L Ferrier, M Leveque, H Eutamene, C Cartier, A Ait-Belgnaoui, A Rosztoczy, F Izbeki, J Fioramonti, et al.
Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity
Gut, May 1, 2008; 57(5): 591 - 599.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
N Kalia, J Hardcastle, C Keating, P Pelegrin, D Grundy, L Grasa, and K D Bardhan
Intestinal secretory and absorptive function in Trichinella spiralis mouse model of postinfective gut dysfunction: role of bile acids
Gut, January 1, 2008; 57(1): 41 - 49.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
C. S. Bradley, C. M. Kennedy, A. M. Turcea, S. S. C. Rao, and I. E. Nygaard
Constipation in Pregnancy: Prevalence, Symptoms, and Risk Factors
Obstet. Gynecol., December 1, 2007; 110(6): 1351 - 1357.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
R Spiller, Q Aziz, F Creed, A Emmanuel, L Houghton, P Hungin, R Jones, D Kumar, G Rubin, N Trudgill, et al.
Guidelines on the irritable bowel syndrome: mechanisms and practical management
Gut, December 1, 2007; 56(12): 1770 - 1798.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
T Kaiser, J Langhorst, H Wittkowski, K Becker, A W Friedrich, A Rueffer, G J Dobos, J Roth, and D Foell
Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome
Gut, December 1, 2007; 56(12): 1706 - 1713.
[Abstract] [Full Text] [PDF]


Home page
AAP Grand RoundsHome page
N. S. LeLeiko
GI Flora in IBS
AAP Grand Rounds, October 1, 2007; 18(4): 41 - 42.
[Full Text] [PDF]


Home page
GutHome page
I. Posserud, P.-O. Stotzer, E. S Bjornsson, H. Abrahamsson, and M. Simren
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
Gut, June 1, 2007; 56(6): 802 - 808.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M. Guilarte, J. Santos, I. de Torres, C. Alonso, M. Vicario, L. Ramos, C. Martinez, F. Casellas, E. Saperas, and J. R. Malagelada
Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum
Gut, February 1, 2007; 56(2): 203 - 209.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. K. Sarna
Enteric descending and afferent neural signaling stimulated by giant migrating contractions: essential contributing factors to visceral pain
Am J Physiol Gastrointest Liver Physiol, February 1, 2007; 292(2): G572 - G581.
[Abstract] [Full Text] [PDF]


Home page
ptjournalHome page
K. L Harrington and E. M Haskvitz
Managing a Patient's Constipation With Physical Therapy
Physical Therapy, November 1, 2006; 86(11): 1511 - 1519.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M Di Stefano, E Miceli, A Missanelli, S Mazzocchi, and G R Corazza
Meal induced rectosigmoid tone modification: a low caloric meal accurately separates functional and organic gastrointestinal disease patients
Gut, October 1, 2006; 55(10): 1409 - 1414.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
J. Maukonen, R. Satokari, J. Matto, H. Soderlund, T. Mattila-Sandholm, and M. Saarela
Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria.
J. Med. Microbiol., May 1, 2006; 55(Pt 5): 625 - 633.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A Robinson, V Lee, A Kennedy, L Middleton, A Rogers, D G Thompson, and D Reeves
A randomised controlled trial of self-help interventions in patients with a primary care diagnosis of irritable bowel syndrome
Gut, May 1, 2006; 55(5): 643 - 648.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A Schneider, P Enck, K Streitberger, C Weiland, S Bagheri, S Witte, H-C Friederich, W Herzog, and S Zipfel
Acupuncture treatment in irritable bowel syndrome
Gut, May 1, 2006; 55(5): 649 - 654.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
V. R Aggarwal, J. McBeth, J. M Zakrzewska, M. Lunt, and G. J Macfarlane
The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors?
Int. J. Epidemiol., April 1, 2006; 35(2): 468 - 476.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M Simren and P-O Stotzer
Use and abuse of hydrogen breath tests
Gut, March 1, 2006; 55(3): 297 - 303.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
R. Spiller and A. Watson
Digest
Gut, March 1, 2006; 55(3): 297 - 297.
[Full Text] [PDF]


Home page
JAMAHome page
A. J. Lembo
A 54-Year-Old Woman With Constipation-Predominant Irritable Bowel Syndrome
JAMA, February 22, 2006; 295(8): 925 - 933.
[Full Text] [PDF]


Home page
NeurologyHome page
C. L. Kwan, N. E. Diamant, G. Pope, K. Mikula, D. J. Mikulis, and K. D. Davis
Abnormal forebrain activity in functional bowel disorder patients with chronic pain
Neurology, October 25, 2005; 65(8): 1268 - 1277.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
I. Schwetz, J. A. McRoberts, S. V. Coutinho, S. Bradesi, G. Gale, M. Fanselow, M. Million, G. Ohning, Y. Tache, P. M. Plotsky, et al.
Corticotropin-releasing factor receptor 1 mediates acute and delayed stress-induced visceral hyperalgesia in maternally separated Long-Evans rats
Am J Physiol Gastrointest Liver Physiol, October 1, 2005; 289(4): G704 - G712.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
V. Remorgida, N. Ragni, S. Ferrero, P. Anserini, P. Torelli, and E. Fulcheri
How complete is full thickness disc resection of bowel endometriotic lesions? A prospective surgical and histological study
Hum. Reprod., August 1, 2005; 20(8): 2317 - 2320.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
S. Ferrero, L. H. Abbamonte, R. Valentino, and N. Ragni
Abdominal Pain, Bloating, and Urgency
Obstet. Gynecol., July 1, 2005; 106(1): 195 - 195.
[Full Text] [PDF]


Home page
Psychosom. Med.Home page
D. Koszycki, S. Torres, J. E. Swain, and J. Bradwejn
Central Cholecystokinin Activity in Irritable Bowel Syndrome, Panic Disorder, and Healthy Controls
Psychosom Med, July 1, 2005; 67(4): 590 - 595.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
D. E. Baker
Rationale for using serotonergic agents to treat irritable bowel syndrome
Am. J. Health Syst. Pharm., April 1, 2005; 62(7): 700 - 711.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
R. C. Spiller
Irritable bowel syndrome
Br. Med. Bull., March 14, 2005; 72(1): 15 - 29.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
V. Remorgida, N. Ragni, S. Ferrero, P. Anserini, P. Torelli, and E. Fulcheri
The involvement of the interstitial Cajal cells and the enteric nervous system in bowel endometriosis
Hum. Reprod., January 1, 2005; 20(1): 264 - 271.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
G Kristjansson, P Venge, A Wanders, L Loof, and R Hallgren
Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome
Gut, December 1, 2004; 53(12): 1806 - 1812.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
B Coffin, D Bouhassira, J-M Sabate, L Barbe, and R Jian
Alteration of the spinal modulation of nociceptive processing in patients with irritable bowel syndrome
Gut, October 1, 2004; 53(10): 1465 - 1470.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
L-H Wang, X-C Fang, and G-Z Pan
Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis
Gut, August 1, 2004; 53(8): 1096 - 1101.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
I Posserud, P Agerforz, R Ekman, E S Bjornsson, H Abrahamsson, and M Simren
Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress
Gut, August 1, 2004; 53(8): 1102 - 1108.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
J Hammer, G D Eslick, S C Howell, E Altiparmak, and N J Talley
Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia
Gut, May 1, 2004; 53(5): 666 - 672.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
M. Simren, G. Ringstrom, E. S. Bjornsson, and H. Abrahamsson
Treatment With Hypnotherapy Reduces the Sensory and Motor Component of the Gastrocolonic Response in Irritable Bowel Syndrome
Psychosom Med, March 1, 2004; 66(2): 233 - 238.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
G Bassotti, F Chistolini, F Sietchiping-Nzepa, G de Roberto, A Morelli, and G Chiarioni
Biofeedback for pelvic floor dysfunction in constipation
BMJ, February 14, 2004; 328(7436): 393 - 396.
[Full Text] [PDF]


Home page
GutHome page
J S Kalantar, G R Locke, A R Zinsmeister, C M Beighley, and N J Talley
Familial aggregation of irritable bowel syndrome: a prospective study
Gut, December 1, 2003; 52(12): 1703 - 1707.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
G. Bassotti, F. Chistolini, F. S. Nzepa, and A. Morelli
Colonic Propulsive Impairment in Intractable Slow-Transit Constipation
Arch Surg, December 1, 2003; 138(12): 1302 - 1304.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
T. M. Ball and J. A. Weydert
Methodological Challenges to Treatment Trials for Recurrent Abdominal Pain in Children
Arch Pediatr Adolesc Med, November 1, 2003; 157(11): 1121 - 1127.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
P D Thomas, A Forbes, J Green, P Howdle, R Long, R Playford, M Sheridan, R Stevens, R Valori, J Walters, et al.
Guidelines for the investigation of chronic diarrhoea, 2nd edition
Gut, July 1, 2003; 52(90005): v1 - 15.
[Full Text]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Delgado-Aros, H. J. Chial, M. Camilleri, L. A. Szarka, F. T. Weber, J. Jacob, I. Ferber, S. McKinzie, D. D. Burton, and A. R. Zinsmeister
Effects of a kappa -opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans
Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G558 - G566.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
K R Neal, L Barker, and R C Spiller
Prognosis in post-infective irritable bowel syndrome: a six year follow up study
Gut, September 1, 2002; 51(3): 410 - 413.
[Abstract] [Full Text]


Home page
Biol Res NursHome page
S. A. Motzer, M. Jarrett, M. M. Heitkemper, and J. Tsuji
Natural Killer Cell Function and Psychological Distress in Women with and without Irritable Bowel Syndrome
Biol Res Nurs, July 1, 2002; 4(1): 31 - 42.
[Abstract] [PDF]


Home page
GutHome page
J Fioramonti and L Bueno
Centrally acting agents and visceral sensitivity
Gut, July 1, 2002; 51(90001): i91 - 95.
[Abstract] [Full Text]


Home page
Qual Saf Health CareHome page
M Petticrew, M Rodgers, and A Booth
Effectiveness of laxatives in adults
Qual. Saf. Health Care, December 1, 2001; 10(4): 268 - 273.
[Full Text] [PDF]


Home page
GutHome page
J Jones, J Boorman, P Cann, A Forbes, J Gomborone, K Heaton, P Hungin, D Kumar, G Libby, R Spiller, et al.
British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome
Gut, November 1, 2000; 47(90002): ii1 - 19.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1999 BMJ Publishing Group Ltd & British Society of Gastroenterology